Literature DB >> 25340986

Ebola hemorrhagic fever: genetic biomarkers and vaccine development.

Erin Oliphant1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25340986      PMCID： PMC4216996          DOI： 10.1089/gtmb.2014.1560

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN： 1945-0257


× No keyword cloud information.
  6 in total

1.  Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques.

Authors:  Douglas S Reed; Lisa E Hensley; Joan B Geisbert; Peter B Jahrling; Thomas W Geisbert
Journal:  Viral Immunol       Date:  2004       Impact factor: 2.257

2.  Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Authors:  Thomas W Geisbert; Lisa E Hensley; Peter B Jahrling; Tom Larsen; Joan B Geisbert; Jason Paragas; Howard A Young; Terry M Fredeking; William E Rote; George P Vlasuk
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

3.  Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.

Authors:  Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Stuart T Nichol; Jonathan S Towner; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

4.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

Authors:  Thomas W Geisbert; Lisa E Hensley; Tom Larsen; Howard A Young; Douglas S Reed; Joan B Geisbert; Dana P Scott; Elliott Kagan; Peter B Jahrling; Kelly J Davis
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

5.  Transcriptional correlates of disease outcome in anticoagulant-treated non-human primates infected with ebolavirus.

Authors:  Sara Garamszegi; Judy Y Yen; Anna N Honko; Joan B Geisbert; Kathleen H Rubins; Thomas W Geisbert; Yu Xia; Lisa E Hensley; John H Connor
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31

6.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Authors:  Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger
Journal:  Nature       Date:  2014-08-29       Impact factor: 49.962
  6 in total
  1 in total

1.  Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak.

Authors:  Mark D Kieh; Elim M Cho; Ian A Myles
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.